Cancer

Items 61-70 of 93

per page
Set Descending Direction
  1. Parthenolide
    CAS  20554-84-1
    AG-CN2-0455
    AG-CN2-0455-M01010 mg
    CHF 35.00
    AG-CN2-0455-M05050 mg
    CHF 80.00
    AG-CN2-0455-M250250 mg
    CHF 240.00
    Parthenolide
  2. PD-1 (human) ELISA Kit
    AG-45B-0015
    AG-45B-0015-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  3. PD-L1 (human) ELISA Kit
    AG-45B-0016
    AG-45B-0016-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  4. PLpro (SARS-CoV-2) (rec.) (His)
    SBB-DE0127
    SBB-DE0127-C05050 µg
    CHF 322.00
  5. Polyinosinic-polycytidylic acid [Poly(I:C)] Endotoxin-free (sterile)
    CAS  31852-29-6
    IAX-200-021
    IAX-200-021-M0022 mg
    CHF 148.00
    IAX-200-021-M0055 mg
    CHF 205.00
    IAX-200-021-30053 x 5 mg
    CHF 556.00
    Polyinosinic-polycytidylic acid [Poly(I:C)] Endotoxin-free (sterile)
  6. PSGL-1 (human):Fc (human) (rec.)
    AG-40B-0190
    AG-40B-0190-C05050 µg
    CHF 420.00
    AG-40B-0190-C500500 µg
    CHF 3'360.00
    PSGL-1 (human):Fc (human) (rec.)
  7. Q-VD-OPh
    CAS  1135695-98-5 (anhydrous)
    AG-CP3-0006
    AG-CP3-0006-M0011 mg
    CHF 190.00
    AG-CP3-0006-30013 x 1 mg
    CHF 480.00
    AG-CP3-0006-M0055 mg
    CHF 750.00
    Q-VD-OPh
  8. Q-VE-OPh (Negative Control)
    AG-CP3-0007
    AG-CP3-0007-M0011 mg
    CHF 225.00
    Q-VE-OPh (Negative Control)

Items 61-70 of 93

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.